Alpha Cognition (ACOG) Liabilities and Shareholders Equity (2023 - 2026)
Alpha Cognition (ACOG) posted quarterly Liabilities and Shareholders Equity of $79.7 million for Q4 2025, up 57.14% year-over-year from $50.7 million in Q4 2024, and up 72.2% quarter-over-quarter from $46.3 million in Q3 2025.
Alpha Cognition (ACOG) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
Alpha Cognition's Liabilities and Shareholders Equity history runs 3 years deep, the most recent figure standing at $79.7 million for Q4 2025.
- In Q4 2025, Liabilities and Shareholders Equity rose 57.14% year-over-year to $79.7 million; the TTM figure through Dec 2025 stood at $219.8 million (up 279.9% YoY), while the FY2025 annual figure was $79.7 million, up 57.14% from the prior year.
- Liabilities and Shareholders Equity for Q4 2025 stood at $79.7 million, up from $46.3 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $79.7 million in Q4 2025, with the low at $2.1 million in Q2 2024.
- The 3-year median for Liabilities and Shareholders Equity is $45.7 million (2025), against an average of $35.0 million.
- Peak annual rise in Liabilities and Shareholders Equity reached 2067.29% in 2025, while the deepest fall reached 57.14% in 2025.
- Alpha Cognition's Liabilities and Shareholders Equity stood at $2.5 million in 2023, then soared by 1969.06% to $50.7 million in 2024, then soared by 57.14% to $79.7 million in 2025.
- Business Quant data shows ACOG's Liabilities and Shareholders Equity at $79.7 million in Q4 2025, $46.3 million in Q3 2025, and $45.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Alpha Cognition | 219.48 Mn | 178.04 Mn | 5.70 Mn | 64.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 64.52 Mn |
| Dec 31, 2025 | 79.73 Mn |
| Sep 30, 2025 | 46.30 Mn |
| Jun 30, 2025 | 45.12 Mn |
| Mar 31, 2025 | 48.61 Mn |
| Dec 31, 2024 | 50.74 Mn |
| Sep 30, 2024 | 5.03 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Dec 31, 2023 | 2.45 Mn |